{"name": "Excelimmune",
 "permalink": "excelimmune",
 "crunchbase_url": "http://www.crunchbase.com/company/excelimmune",
 "homepage_url": "http://www.excelimmune.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "Pre-Clinical BioPharma Company",
 "created_at": "Tue Apr 27 08:19:08 UTC 2010",
 "updated_at": "Wed Feb 01 02:10:16 UTC 2012",
 "overview": "\u003Cp\u003EExcelimmune, Inc. is a biopharmaceutical company specializing in the development of fully human recombinant polyclonal antibodies for therapeutic use. This technology is applicable in the treatment of infectious diseases, as well as protein diseases and cancer. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       25],
      "assets/images/resized/0008/5049/85049v1-max-150x150.png"],
     [[250,
       42],
      "assets/images/resized/0008/5049/85049v1-max-250x250.png"],
     [[268,
       46],
      "assets/images/resized/0008/5049/85049v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$28M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://onbiovc.com/excelimmune-inc-series-b-1m/",
    "source_description": "Excelimmune, Inc.: Series B $1M ",
    "raised_amount": 1000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 4,
    "funded_day": 14,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/excelimmune-garners-4-5m-new-financing/2010-07-07?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Excelimmune garners $4.5M in new financing",
    "raised_amount": 4500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 7,
    "funded_day": 7,
    "investments":
     []},
   {"round_code": "b",
    "source_url": "http://www.masshightech.com/stories/2011/05/30/daily1-MRSA-focused-biotech-Excelimmune-raises-105M.html",
    "source_description": "MRSA-focused biotech Excelimmune raises $10.5M",
    "raised_amount": 10500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 5,
    "funded_day": 31,
    "investments":
     []},
   {"round_code": "c",
    "source_url": "http://www.finsmes.com/2011/12/excelimmune-raises-12m.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Excelimmune Raises $12M",
    "raised_amount": 12000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 12,
    "funded_day": 20,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Headquarters",
    "address1": "12-B Cabot Road ",
    "address2": "",
    "zip_code": "01801",
    "city": "Woburn ",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}